Miscellaneous Metabolic Disorders
Gene: ABHD12
Well-established disease gene (see OMIM). Biallelic variants cause an inborn error of endocannabinoid metabolism.
Sources: NHS GMSCreated: 22 Jan 2021, 3:10 p.m.
      Mode of inheritance
      BIALLELIC, autosomal or pseudoautosomal
    
      Phenotypes
      Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract MIM#612674
    
Publications
Variants in this GENE are reported as part of current diagnostic practice
More than 5 unrelated families reported, progressive condition.Created: 24 Sep 2020, 9:31 p.m. | Last Modified: 24 Sep 2020, 9:31 p.m.
Panel Version: 0.4566
      Mode of inheritance
      BIALLELIC, autosomal or pseudoautosomal
    
      Phenotypes
      Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, MIM# 612674
    
Publications
Phenotypes for gene: ABHD12 were changed from Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract MIM#612674 to Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract MIM#612674; disorder of of endocannabinoid metabolism
Gene: abhd12 has been classified as Green List (High Evidence).
Gene: abhd12 has been classified as Green List (High Evidence).
gene: ABHD12 was added gene: ABHD12 was added to Miscellaneous Metabolic Disorders. Sources: NHS GMS Mode of inheritance for gene: ABHD12 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ABHD12 were set to 20797687 Phenotypes for gene: ABHD12 were set to Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract MIM#612674 Review for gene: ABHD12 was set to GREEN gene: ABHD12 was marked as current diagnostic